4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Lunai Bioworks Inc. (LNAI) operates in the Biotechnology industry and is headquartered in Los Angeles, United States with about 29 employees. Its market capitalization is roughly $13 million. In the fiscal year ended 2025-06-30, LNAI reported $0M in revenue and ($178M) in net income.
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC.
Interactive charts & full statements → Open the LNAI valuation workbench →
| Income statement | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Gross Profit | — | $0M | $0M | — |
| Operating Income (EBIT) | ($18M) | ($27M) | ($20M) | ($23M) |
| Net Income | ($178M) | ($88M) | ($40M) | ($113M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Gross Profit | $0M | — | — | — | $0M | — |
| Operating Income (EBIT) | ($1M) | ($2M) | ($2M) | ($4M) | ($4M) | — |
| Net Income | ($3M) | ($2M) | $3M | ($127M) | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Assets | $8M | $163M | $58M | $85M |
| Total Liabilities | $30M | $31M | $12M | $12M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LNAI viewer.
About TickerBase · Data methodology & sources